Clinical Trial: Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: An Observational, Non-Interventional, Multi-Center, Multi-National Study of Patients With aTypical Hemolytic-Uremic Syndrome (aHUS Registry)

Brief Summary: Post-marketing safety data on patients treated and untreated with eculizumab.